This webinar will explore current management and treatment guidelines for Chronic Obstructive Pulmonary Disease (COPD). COPD is a group of progressive lung diseases, with emphysema and chronic bronchitis the most common. An estimated 30 million U.S. patients have COPD. Pharmacologic management of COPD can ease symptoms, prevent complications, and generally slow disease progression, reducing exacerbations. The recommended pharmacotherapy drug classes for COPD treatment will be presented, utilizing a case-based approach.